These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14554016)

  • 1. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents.
    Greenfield RA; Bronze MS
    Drug Discov Today; 2003 Oct; 8(19):881-8. PubMed ID: 14554016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Germs and toxins in bioterrorism].
    Inoue N
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():81-91. PubMed ID: 12722194
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparing for bioterrorism: category A agents.
    Persell DJ; Arangie P; Young C; Stokes EN; Payne WC; Skorga P; Gilbert-Palmer D
    Nurse Pract; 2001 Dec; 26(12):12-5, 19-24, 27; quiz 28-9. PubMed ID: 11809039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical aspects of bio-terrorism.
    Balali-Mood M; Moshiri M; Etemad L
    Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioterrorism. Clinical recognition and primary management.
    Branda JA; Ruoff K
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S116-23. PubMed ID: 14569808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioterrorism.
    Steinhauer R
    RN; 2002 Mar; 65(3):48-54; quiz 55. PubMed ID: 11961869
    [No Abstract]   [Full Text] [Related]  

  • 8. Being prepared: bioterrorism and mass prophylaxis: part II.
    Weant KA; Bailey AM; Fleishaker EL; Justice SB
    Adv Emerg Nurs J; 2014; 36(4):307-17; quiz 318-9. PubMed ID: 25356890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella tularensis as a potential agent of bioterrorism?
    Maurin M
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):141-4. PubMed ID: 25413334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents.
    Brouillard JE; Terriff CM; Tofan A; Garrison MW
    Pharmacotherapy; 2006 Jan; 26(1):3-14. PubMed ID: 16506347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioterrorism: class A agents and their potential presentations in immunocompromised patients.
    Richard JL; Grimes DE
    Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for Category A bioterrorism diseases.
    Lutwick LI; Nierengarten MB
    Expert Opin Biol Ther; 2002 Dec; 2(8):883-93. PubMed ID: 12517267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines, biological warfare, and bioterrorism.
    Polgreen PM; Helms C
    Prim Care; 2001 Dec; 28(4):807-21, vii. PubMed ID: 11739031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating the threat of anthrax: a quantitative structure-activity relationship approach.
    Verma RP; Hansch C
    Mol Pharm; 2008; 5(5):745-59. PubMed ID: 18611038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room.
    Cunha BA
    Clin Microbiol Infect; 2002 Aug; 8(8):489-503. PubMed ID: 12197871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioterrorism].
    Sata T
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confronting bioterrorism: physicians on the front line.
    Varkey P; Poland GA; Cockerill FR; Smith TF; Hagen PT
    Mayo Clin Proc; 2002 Jul; 77(7):661-72. PubMed ID: 12108604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA; Broussard LA
    Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiology laboratory's role in response to bioterrorism.
    Robinson-Dunn B
    Arch Pathol Lab Med; 2002 Mar; 126(3):291-4. PubMed ID: 11860302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients exposed to biologic weapons.
    Yetman RJ; Parks D; Taft E
    J Pediatr Health Care; 2002; 16(5):256-61. PubMed ID: 12226595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.